Marvell Technology, Inc. (MRVL) NASDAQ
109.51
+2.4(+2.24%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
109.51
+2.4(+2.24%)
Currency In USD
| Previous Close | 107.11 |
| Open | 109.42 |
| Day High | 111.89 |
| Day Low | 106 |
| 52-Week High | 111.89 |
| 52-Week Low | 48.09 |
| Volume | 22.66M |
| Average Volume | 18.28M |
| Market Cap | 95.74B |
| PE | 35.67 |
| EPS | 3.07 |
| Moving Average 50 Days | 85.48 |
| Moving Average 200 Days | 81.82 |
| Change | 2.4 |
Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite
Newsfile
Dec 22, 2025 7:07 PM GMT
Toronto, Ontario--(Newsfile Corp. - December 22, 2025) - Rod Matheson, Chief Executive Officer, and Mark Williams, Chief Strategy Officer, from Marvel Biosciences Corp. (the "Company") (TSXV: MRVL), shares the Company's story in an interview with TMX